Literature DB >> 21706218

Reactive calcium-phosphate-containing poly(ester-co-ether) methacrylate bone adhesives: setting, degradation and drug release considerations.

Xin Zhao1, Irwin Olsen, Jonathan Pratten, Jonathan C Knowles, Anne M Young.   

Abstract

This study has investigated novel bone adhesives consisting of fluid photo-polymerizable poly(lactide-co-propylene glycol-co-lactide)dimethacrylate (PGLA-DMA) mixed with systematically varying fillers of β-tricalcium phosphate (β-TCP) and monocalcium phosphate monohydrate (MCPM), for the delivery of an antibacterial drug chlorhexidine (CHX). All formulations were found to polymerize fully within 200 s after exposure to blue light. In addition, water sorption by the polymerized materials catalyzed varying filler conversion to dicalcium phosphate (DCP) (i.e. brushite and monetite). With greater DCP levels, faster degradation was observed. Moreover, increase in total filler content enhanced CHX release, associated with higher antibacterial activity. These findings thus suggest that such rapid-setting and degradable adhesives with controllable drug delivery property could have potential clinical value as bone adhesives with antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21706218     DOI: 10.1007/s10856-011-4378-4

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  15 in total

Review 1.  Advances in our understanding of the bone and joint pathology caused by Staphylococcus aureus infection.

Authors:  S P Nair; R J Williams; B Henderson
Journal:  Rheumatology (Oxford)       Date:  2000-08       Impact factor: 7.580

2.  Chlorhexidine release from room temperature polymerising methacrylate systems.

Authors:  P D Riggs; M Braden; M Patel
Journal:  Biomaterials       Date:  2000-02       Impact factor: 12.479

3.  BSAC standardized disc susceptibility testing method (version 7).

Authors:  J M Andrews
Journal:  J Antimicrob Chemother       Date:  2008-05-12       Impact factor: 5.790

Review 4.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.

Authors:  Viviana Mouriño; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

5.  Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models.

Authors:  U Ripamonti
Journal:  Biomaterials       Date:  1996-01       Impact factor: 12.479

6.  The sustaining effect of three polymers on the release of chlorhexidine from a controlled release drug device for root canal disinfection.

Authors:  Doug-Youn Lee; Larz S W Spångberg; Young-Bin Bok; Chang-Young Lee; Kee-Yeon Kum
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2005-07

7.  Chemical characterization of a degradable polymeric bone adhesive containing hydrolysable fillers and interpretation of anomalous mechanical properties.

Authors:  Anne M Young; Sze Man Ho; Ensanya A Abou Neel; Ifty Ahmed; Jake E Barralet; Jonathan C Knowles; Showan N Nazhat
Journal:  Acta Biomater       Date:  2009-02-20       Impact factor: 8.947

8.  Reactive calcium-phosphate-containing poly(ester-co-ether) methacrylate bone adhesives: chemical, mechanical and biological considerations.

Authors:  Xin Zhao; Irwin Olsen; Haoying Li; Kris Gellynck; Paul G Buxton; Jonathan C Knowles; Vehid Salih; Anne M Young
Journal:  Acta Biomater       Date:  2009-10-01       Impact factor: 8.947

9.  Development of remineralizing, antibacterial dental materials.

Authors:  Idris Mehdawi; Ensanya A Abou Neel; Sabeel P Valappil; Graham Palmer; Vehid Salih; Jonathan Pratten; Dave A Spratt; Anne M Young
Journal:  Acta Biomater       Date:  2009-03-31       Impact factor: 8.947

10.  Maximum inhibitory dilution of mouthwashes containing chlorhexidine and polyhexamethylene biguanide against salivary Staphylococcus aureus.

Authors:  Andresa Piacezzi Nascimento; Juliane Maria Guerreiro Tanomaru; Fumio Matoba-Júnior; Evandro Watanabe; Mario Tanomaru-Filho; Izabel Yoko Ito
Journal:  J Appl Oral Sci       Date:  2008 Sep-Oct       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.